Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report), Edgewise Therapeutics (EWTX – Research Report) and Agilon Health (AGL – Research Report).
Teladoc (TDOC)
Citi analyst Daniel Grosslight maintained a Hold rating on Teladoc yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $18.12, close to its 52-week low of $17.78.
According to TipRanks.com, Grosslight is a 4-star analyst with an average return of
Teladoc has an analyst consensus of Moderate Buy, with a price target consensus of $26.33, implying a 44.8% upside from current levels. In a report issued on October 11, Evercore ISI also maintained a Hold rating on the stock with a $19.00 price target.
See the top stocks recommended by analysts >>
Edgewise Therapeutics (EWTX)
In a report released today, Leonid Timashev from RBC Capital maintained a Buy rating on Edgewise Therapeutics, with a price target of $28.00. The company’s shares closed last Tuesday at $6.95.
According to TipRanks.com, Timashev has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Edgewise Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $26.67.
Agilon Health (AGL)
In a report issued on October 20, Jailendra Singh from Truist Financial maintained a Buy rating on Agilon Health, with a price target of $27.00. The company’s shares closed last Tuesday at $18.88.
According to TipRanks.com, Singh is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Agilon Health with a $27.00 average price target, representing a 42.8% upside. In a report issued on October 20, Benchmark Co. also initiated coverage with a Buy rating on the stock with a $28.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TDOC:
